TRB Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$39.9M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$18.3M |
| 3 |
Visa
V
|
+$7.79M |
| 4 |
S&P Global
SPGI
|
+$7.04M |
| 5 |
Fair Isaac
FICO
|
+$6.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FNCH
Finch Therapeutics Group, Inc. Common Stock
FNCH
|
+$274K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 52.28% |
| 2 | Financials | 19.86% |
| 3 | Healthcare | 0% |
Similar funds
TRB Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, TRB Advisors held 10 positions worth $214M, up 111% from $102M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
TRB Advisors deployed $89.1M of net new capital in Q1 2023, opening 6 new positions and adding to 1 existing holding. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 100,000 shares worth $40.9M.
By sector, the portfolio is most concentrated in Technology at 52% of assets, down from 83% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the most notable exit was Finch Therapeutics Group, Inc. Common Stock, an estimated $274K sold.
- TRB Advisors's largest Q1 2023 buy was State Street SPDR S&P 500 ETF Trust: 100,000 shares worth $40.9M.
- TRB Advisors added most to Visa in Q1 2023, an estimated $7.79M increase.
- TRB Advisors fully exited Finch Therapeutics Group, Inc. Common Stock in Q1 2023, selling an estimated $274K.
- TRB Advisors's ten largest holdings make up 100% of its $214M portfolio in Q1 2023.
- TRB Advisors opened 6 new positions and closed 1 in Q1 2023.
- TRB Advisors's portfolio value rose 111% quarter-over-quarter to $214M.
Based on TRB Advisors's 13F filing for Q1 2023, filed 24 Apr 2023.